PHR
Fiscal year ends January Quarters are offset from the calendar — Q1 is Feb–Apr

Phreesia, Inc. is a healthcare technology company founded in 2005 that provides an integrated software, payments, and engagement platform for healthcare organizations. The company serves ambulatory practices, health systems, hospitals, life sciences companies, and government entities, primarily in the United States. Its solutions address access to care, affordability, and patient health outcomes through capabilities such as digital patient intake, scheduling, eligibility verification, and payment processing. Key products include MediFind, an online provider directory, and AI-enabled workflows for appointment optimization and patient communications. The company generates revenue through subscription services, payment solutions including financing and processing fees, and Network Solutions, which facilitates compliant engagement for life sciences companies. Phreesia integrates with major electronic medical record and practice management systems and completed the acquisition of AccessOne Parent Holdings, Inc. in fiscal year 2026 to expand its healthcare payments offerings.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Health Information Services Homepage phreesia.com
Sector Healthcare IR page ir.phreesia.com/home/default.aspx
Tags
patient intake, healthcare payments, revenue cycle management, digital scheduling, patient engagement, eligibility verification, life sciences marketing, electronic health record integration, ai-enabled workflows, MediFind, AccessOne, AccessOne Parent Holdings Inc., Network Solutions
Press page phreesia.com/newsroom

Metrics

Valuation  
Market cap $ 605.192M
Market cap (USD) $ 605.192M
P/E 54.17
PEG —
P/BV 1.63
P/S 1.22
P/OCF 6.62
P/FCF 7.49
Dividend yield —
Turnover / mcap —
Returns  
ROE 0.77%
ROI 0.67%
ROIC -1.4%
Profit margin 0.49%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 0.31%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 25
Quality score 41.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue 467.819M 419.813M 356.299M 280.91M 213.233M 148.677M 124.784M 99.889M
Net profit 2.306M -58.527M -136.885M -176.146M -118.161M -27.292M -20.293M -15.062M
Free cash flow 67.713M 23.672M -38.184M -94.855M -93.13M -8.351M -6.189M -6.854M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Share price 16.36 29.5 25.99 38 32.62 66.28 31.05 —
Price performance 12m -0.45 0.14 -0.32 0.17 -0.51 1.14 — —

Filed figures

Figure Jan 2017 Jan 2018 Jan 2019 Jan 2020 Jan 2021 Jan 2022 Jan 2023 Jan 2024 Jan 2025 Jan 2026
Balance sheet detail
Trade receivables (USD) — — 16.1M 22M 29.1M 40.3M 51.4M 64.9M 73.6M 97.5M
↳ YoY growth +36.4% +32.2% +38.6% +27.6% +26.2% +13.5% +32.4%
↳ 5y CAGR +32.1% +27.3% +27.4%
Borrowings, current (USD) — — 97,222 0.00 4.86M 5.82M 5.17M 6.06M 8.04M 7.97M
Borrowings, non-current (USD) — — 27.9M 19.4M 6.47M 7.42M 2.73M 5.4M 8.15M 92.1M
Lease liabilities (USD) — — — 4.42M 12.7M 15.4M 8.93M 8.84M 15.9M 9.79M
Cash and deposits (USD) 2.32M 10.5M 1.54M 90.3M 219M 314M 177M 87.5M 84.2M 73.8M
Intangible assets (USD) — — 1.44M 1.2M 2.73M 12.8M 11.4M 31.6M 28.1M 79.8M
Right-of-use assets (USD) — — — 0.00 2.65M 2.34M 569,000 266,000 1.48M 2M
Net debt (borrowings + leases - cash) (USD) — — 26.5M -70.9M -195M -285M -160M -67.2M -52.2M 36.1M
Cash flow detail
Operating cash flow (USD) — -11.1M -2.13M 826,000 2.89M -74.7M -90.1M -32.4M 32.4M 78.8M
Purchases of property, plant and equipment (USD) — -6.59M -4.72M -7.02M -11.2M -18.4M -4.73M -5.81M -8.71M -11.1M
Change in receivables (cash effect) (USD) — -3.38M -3.77M -5.91M -6.62M -10.2M -11.1M -11.2M -8.81M -23.4M
Change in payables (cash effect) (USD) — -2.06M 2.37M -30,000 -3.82M 2.88M 4.77M -1.99M -3.23M 5.26M
Interest paid (cash effect) (USD) — -2.8M -2.8M -2.31M -1.47M -802,000 -763,000 -1.31M -2.19M -1.61M
Income taxes paid (cash effect) (USD) — — 0.00 0.00 -64,000 -49,000 -39,000 -37,000 -3.07M -1.9M
Share-based compensation (USD) — 805,000 1.45M 6.18M 13.5M 36.1M 58.8M 71.6M 67M 67.5M
Operating cash flow before change in receivables (USD) — -7.76M 1.64M 6.73M 9.51M -64.5M -79M -21.2M 41.2M 102M
Free cash flow (OCF - PPE - intangibles) (USD) — -17.7M -6.85M -6.19M -8.35M -93.1M -94.9M -38.2M 23.7M 67.7M
Income detail
Research and development expense (USD) — 11.4M 14.3M 18.6M 22.6M 52.3M 91.2M 112M 117M 121M
↳ 5y CAGR +51.6% +50.9% +44.5% +40.0%
Total comprehensive income (USD) — — — — — — -176M -137M -58.6M 1.98M
Comprehensive income to owners (USD) — — — — — — -176M -137M -58.6M 1.98M
Provision for credit losses (USD) — — — — 454,000 212,000 587,000 377,000 1.05M 1.02M
Credit cost ratio (credit losses / average receivables) (%) — — — — 1.8% 0.6% 1.3% 0.6% 1.5% 1.2%
Reported Apr 23, 2020 Apr 23, 2020 Mar 31, 2021 Mar 31, 2021 Mar 31, 2021 Mar 31, 2022 Mar 13, 2025 Mar 13, 2025 Mar 13, 2025 Mar 31, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

November 5, 2026

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)-- Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2027 financial results after the close of market trading on Wednesday, Dec. 2, 2026. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com . Phreesia will then hold a conference call to discuss its fiscal third quarter results starting at 5PM Eastern Time on the same day.

To participate in the company's live conference call and webcast, please dial (833) 461-5787, or (626) 884-3620 for international participants, using conference code number 422859411, or visit the “Events & Presentations” section of ir.phreesia.com . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

ABOUT PHREESIA

Phreesia is a trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025—1 in 6 visits across the U.S. This scale allows Phreesia to make meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. To learn more, visit phreesia.com .

Investors:
Balaji Gandhi
Phreesia, Inc.
[email protected]

(929) 506-4950

Media:
Nicole Gist
Phreesia, Inc.
[email protected]

(407) 760-6274

Source: Phreesia, Inc.

Multimedia Files:

View All News

Phreesia Logo

Quick Links

Published

November 3, 2026

ALL-REMOTE COMPANY/WILMINGTON, Del. — Nov. 3, 2026 — Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Sophia Wagner, Vice President of Product Engineering, has been named to Becker’s Hospital Review’s 2026 list of Health IT & Revenue Cycle Up-and-Comers(this link opens in new window) .

The list recognizes emerging leaders at hospitals, health systems and healthcare companies who are advancing technology, improving financial performance and guiding organizational growth. Becker’s developed the list through nominations and editorial research.

In her current role, Sophia leads teams across product management, engineering and operations, supporting Phreesia’s payments and provider financing businesses. She sets product vision and guides execution for a portfolio that includes payment facilitation and processing, financing, patient payments, and patient billing and statements. Her responsibilities include oversight of nearly $5 billion in annual payment processing volume and continued development of provider financing capabilities following Phreesia’s acquisition of AccessOne.

“Sophia is one of the sharpest, most resilient leaders I know,” said Kristin Roberts, Senior Vice President of Product at Phreesia. “She combines rigorous critical thinking with a deep command of the revenue cycle market and has a rare ability to turn opportunity into meaningful impact for both Phreesia and our clients.”

“Being recognized by Becker’s is an honor,” said Sophia Wagner, Vice President of Product Engineering at Phreesia. “The most rewarding part of my work is bringing teams together to turn a product vision into something that helps patients and healthcare organizations. I’m grateful to work with colleagues who care deeply about the details and share a commitment to making the financial side of healthcare easier.”

Published

October 14, 2026

ALL-REMOTE COMPANY/WILMINGTON, Del. — Oct. 8, 2026 — Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Michael Rasbury, Vice President of AccessOne Solutions, has been named to Becker’s Hospital Review’s 2026 list of Rising Stars: Healthcare Leaders Under 40 .

The annual list recognizes healthcare leaders under 40 who are bringing new perspectives to industry challenges and driving change across healthcare. Becker’s developed the 2026 list through nominations and editorial research.

In his current role, Michael leads Phreesia’s AccessOne business, focusing on patient financial engagement, implementation quality and delivering value for healthcare organizations. He oversees a team of approximately 80 employees supporting AccessOne, which helps healthcare organizations improve collections and cash flow while giving patients flexible options for managing their healthcare expenses.

Michael has spent more than a decade at Phreesia, advancing from project manager to vice president while building and leading teams focused on strong client partnerships and operational excellence. Before taking on his current role, he led Phreesia’s client services organization and a global team of consultants across the U.S., Canada and India. Under his leadership, Phreesia improved implementation efficiency, ensuring that client projects get underway more quickly. Michael also led efforts to improve onboarding, strengthen client relationships and create a more consistent experience for healthcare organizations throughout the implementation process.

“Being recognized by Becker’s is an honor,” said Michael Rasbury, Vice President of AccessOne Solutions at Phreesia. “What motivates me is building teams and processes that help our clients succeed and make the financial side of healthcare easier for patients. I’m excited to continue that work as we grow AccessOne and create even more value for the healthcare organizations we serve.”

Prompts

Phreesia, Inc. (ticker PHR), listed in United States.

ETFs Holding Phreesia, Inc.

ETF Weight in ETF Shares Market value As of
AFSM 0.44% 49,885 $ 639.526K Nov 16, 2026
LGHT 0.15% 355 $ 3,652.95 Jun 30, 2026
SYZ 0.13% 8,744 $ 89.976K Jun 30, 2026
FSEG 0.12% 688 $ 7,079.52 Jun 30, 2026
ESSC 0.12% 3,897 $ 41.815K Jul 31, 2026
VFVA 0.10% 74,746 $ 912.649K Aug 31, 2026
PSC 0.08% 173,056 $ 1.781M Jun 30, 2026
FESM 0.07% 416,545 $ 4.286M Jun 30, 2026
RESM 0.02% 85 $ 874.65 Jun 30, 2026
AVSC 0.02% 43,136 $ 553.004K Nov 16, 2026
DFAS 0.01% 201,242 $ 2.54M Nov 12, 2026
DFAT 0.00% 11,918 $ 150.405K Nov 12, 2026
EBI 0.00% 8 $ 97.68 Aug 31, 2026